Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here